• Mashup Score: 0
    2024 Abstracts - ASCCP - 2 year(s) ago

    DEADLINE:  November 10, 2023 Submit and Present Your Research! Categories: Anal/Perianal Disease – Epidemiology, Screening, Treatment Effect of Anogenital Tract Disease on Sexuality Basic Science and Genetics Cervical Squamous Intraepithelial Lesions – Epidemiology, Screening, Treatment Cervical Colposcopy Disparities and Barriers in Anogenital Tract Disease – Screening, Treatment, Clinical…

    Tweet Tweets with this article
    • Calling all #researchers! Share your findings at #ASCCP2024. Submit your abstract to be part of the Scientific Meeting on Anogenital and HPV-Related Diseases. The submission deadline is Nov 10, 2023! https://t.co/A723uPFjA0 https://t.co/rHYhb4VAdv

  • Mashup Score: 0

    Registration Open – In-Person These are live, face-to-face, courses where students meet for (4) days with their colleagues and faculty. There is a non-CME hands-on portion to this course. San Diego, CA July 12, 2023 – July 15, 2023 …

    Tweet Tweets with this article
    • ⌛ Time is running out! Secure your hotel room in the room block by Friday to receive the ASCCP discounted rate at the beautiful @RBernardoInn in San Diego, CA! Don't delay any longer, book your room before tomorrow! https://t.co/oBngvrV9jy #July2023CompCourse #SanDiegoBound https://t.co/RJviFZ6Lqm

  • Mashup Score: 0

    Philip E. Castle, PhD, MPH Global Cervical Cancer Control: Will We Ever Get That Rock To The Top Of The Hill? Dr. Castle was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle…

    Tweet Tweets with this article
    • Should you begin #screening for #cervical #cancer under age 25? Should you stop screening over age 65? Tune in to the Virtual #ASCCP2023 to hear the on-demand debate as experts share their opinions over the debate in screening guidelines. Register now at: https://t.co/3RmIdRL23c https://t.co/962QBN0sZH

  • Mashup Score: 2
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • RT @JLGTD: May 4-7 is @ASCCP meeting. Abstracts are available on our site https://t.co/UZbgzr05in and https://t.co/MDH615tuS9

  • Mashup Score: 0

    Philip E. Castle, PhD, MPH Global Cervical Cancer Control: Will We Ever Get That Rock To The Top Of The Hill? Dr. Castle was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle…

    Tweet Tweets with this article
    • #TBT and reflect with us on the past in-person 2022 and 2019 Scientific Meetings! We look forward to welcoming you to the upcoming #ASCCP2023 Scientific Meeting on May 4-7, 2023 in Houston, TX. Registration is still open at: https://t.co/3RmIdRL23c. #hpv #colposcopy #networking https://t.co/nG98OUC3Ki

  • Mashup Score: 0

    Philip E. Castle, PhD, MPH Global Cervical Cancer Control: Will We Ever Get That Rock To The Top Of The Hill? Dr. Castle was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle…

    Tweet Tweets with this article
    • Our next Scientific Meeting Spotlight is keynote speaker: Joel Palefsky, MD! We are thrilled to have Dr. Palefsky as one of our keynote speakers for #ASCCP2023! Join us and Dr. Palefsky at #ASCCP2023 by registering at: https://t.co/wamZaWpDw3. https://t.co/1Yq1YnUCsm